[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1223928A1 - 新型結晶性芳烷基胺化合物及其製造方法 - Google Patents

新型結晶性芳烷基胺化合物及其製造方法

Info

Publication number
HK1223928A1
HK1223928A1 HK16112135.3A HK16112135A HK1223928A1 HK 1223928 A1 HK1223928 A1 HK 1223928A1 HK 16112135 A HK16112135 A HK 16112135A HK 1223928 A1 HK1223928 A1 HK 1223928A1
Authority
HK
Hong Kong
Prior art keywords
producing same
novel crystalline
arylalkylamine compound
crystalline arylalkylamine
compound
Prior art date
Application number
HK16112135.3A
Other languages
English (en)
Inventor
Hiroshi Miyazaki
Takao Komasaka
Joji Tsurumoto
Takeshi Uemura
Yuuji Morita
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52628492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1223928(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Publication of HK1223928A1 publication Critical patent/HK1223928A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4021-aryl substituted, e.g. piretanide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK16112135.3A 2013-09-05 2016-10-20 新型結晶性芳烷基胺化合物及其製造方法 HK1223928A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013073954 2013-09-05
PCT/JP2014/073426 WO2015034031A1 (ja) 2013-09-05 2014-09-05 新規な結晶性アリールアルキルアミン化合物およびその製造方法

Publications (1)

Publication Number Publication Date
HK1223928A1 true HK1223928A1 (zh) 2017-08-11

Family

ID=52628492

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16112135.3A HK1223928A1 (zh) 2013-09-05 2016-10-20 新型結晶性芳烷基胺化合物及其製造方法
HK18115431.5A HK1256344A1 (zh) 2013-09-05 2018-12-03 製備氨基吡咯烷衍生物的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18115431.5A HK1256344A1 (zh) 2013-09-05 2018-12-03 製備氨基吡咯烷衍生物的方法

Country Status (8)

Country Link
US (2) US9643920B2 (zh)
EP (2) EP3360858B1 (zh)
KR (6) KR102460388B1 (zh)
CN (2) CN108484469A (zh)
ES (2) ES2699884T3 (zh)
HK (2) HK1223928A1 (zh)
TW (1) TWI637943B (zh)
WO (1) WO2015034031A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017061621A1 (ja) * 2015-10-07 2017-04-13 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
CN110167916B (zh) * 2017-01-13 2022-11-11 日产化学株式会社 芳香族二胺化合物前体的制造方法
JP2020105072A (ja) * 2017-03-24 2020-07-09 協和キリン株式会社 ポリエチレングリコール誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432987A (en) * 1982-04-23 1984-02-21 Pfizer Inc. Crystalline benzenesulfonate salts of sultamicillin
ZA941586B (en) * 1993-03-12 1995-09-07 Upjohn Co Crystalline ceftiofur free acid
JPH0812670A (ja) * 1994-04-26 1996-01-16 Kissei Pharmaceut Co Ltd 新規なピロリジン誘導体
USRE40794E1 (en) * 2001-09-26 2009-06-23 Merck & Co., Inc. Crystalline forms of carbapenem antibiotics and methods of preparation
PL1757582T3 (pl) 2004-05-28 2016-04-29 Mitsubishi Tanabe Pharma Corp Aryloalkiloaminy i sposób ich wytwarzania
JPWO2009107579A1 (ja) * 2008-02-25 2011-06-30 味の素株式会社 コク味付与剤
JP5748666B2 (ja) 2008-12-09 2015-07-15 インテルキム、ソシエダッド アノニマ (6s)−(−)−5,6,7,8−テトラヒドロ−6−[プロピル−(2−チエニル)エチル]アミノ−1−ナフトール(ロチゴチン)の製造のための方法
MX2011012537A (es) 2009-05-29 2011-12-14 Sumitomo Chemical Co Agente para el tratamiento o prevencion de enfermedades asociadas con actividad de factores neurotroficos.

Also Published As

Publication number Publication date
KR20210119581A (ko) 2021-10-05
EP3360858A1 (en) 2018-08-15
US9643920B2 (en) 2017-05-09
CN105517992A (zh) 2016-04-20
EP3042893A1 (en) 2016-07-13
CN108484469A (zh) 2018-09-04
CN105517992B (zh) 2018-06-22
KR102601941B1 (ko) 2023-11-15
EP3042893A4 (en) 2017-02-15
KR102460388B1 (ko) 2022-10-27
WO2015034031A1 (ja) 2015-03-12
TWI637943B (zh) 2018-10-11
EP3360858B1 (en) 2020-04-29
US20160200679A1 (en) 2016-07-14
KR20230159631A (ko) 2023-11-21
US10144708B2 (en) 2018-12-04
ES2795227T3 (es) 2020-11-23
TW201546045A (zh) 2015-12-16
KR102177643B1 (ko) 2020-11-11
US20170267633A1 (en) 2017-09-21
KR20160051833A (ko) 2016-05-11
ES2699884T3 (es) 2019-02-13
HK1256344A1 (zh) 2019-09-20
KR20200093705A (ko) 2020-08-05
KR20220150994A (ko) 2022-11-11
EP3042893B1 (en) 2018-10-31
KR20170102375A (ko) 2017-09-08

Similar Documents

Publication Publication Date Title
EP2955169A4 (en) Novel aryl compound and method for producing the same
PL3006568T3 (pl) Sposób wytwarzania tagatozy
EP3020688A4 (en) ZEOLITE PROCESS
EP3037087A4 (en) Method for producing microparticles
PT2948590T (pt) Método para produção de lenhina de elevada pureza
PT3466431T (pt) Formas cristalinas e métodos para preparação de inibidores de sglt2
EP3087961A4 (en) METHOD FOR PRODUCING A VACUUMABLE ARTICLE
IL244740B (en) A production method for a diazabicyclooctane derivative and an intermediate compound therefor
EP2990409A4 (en) PROCESS FOR PRODUCING A NEW ORGANOMETALLIC COMPLEX AND AN AMINO COMPOUND
EP2977353A4 (en) PROCESS FOR PRODUCING POTASSIUM TITANATE
EP3042960A4 (en) Method for producing ambrein
EP2980066A4 (en) PROCESS FOR PRODUCING ISOCYANATE
SG11201508263WA (en) Method for producing cyclohexanone compound
EP2998395A4 (en) METHOD FOR OBTAINING COMPOSITION CONTAINING LACTASE
EP3061352A4 (en) Method for producing kakiage
EP3051009A4 (en) SIC-EINKRISTALL AND METHOD FOR THE PRODUCTION THEREOF
EP2808376A4 (en) PROCESS FOR PRODUCING A COMPOSITION
HK1223928A1 (zh) 新型結晶性芳烷基胺化合物及其製造方法
EP2980019A4 (en) PROCESS FOR THE PREPARATION OF DDR ZEOLITE CRYSTALS AND METHOD FOR THE PRODUCTION OF A DDR ZEOLITHFOLIR
EP2985369A4 (en) METHOD FOR PRODUCING A SILICON INCREDIENT
EP3026146A4 (en) METHOD FOR MANUFACTURING SiC SUBSTRATES
EP3077414A4 (en) Method for preparing crystalline insulin
PL3069610T3 (pl) Ko-kryształ i sposób jego wytwarzania
HUE037846T2 (hu) Eljárás izocianátok elõállítására
EP2842930A4 (en) PROCESS FOR PRODUCING HYDROXYPHENYLCYCLOHEXANOL COMPOUND